Companies / Travere Therapeutics, Inc. / Activity
Activity — Travere Therapeutics, Inc.
84 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| May 19, 2026 | Coughlin Timothy Director | Grant | Common Stock | $0 | +4K +7.66% | 56,250 0.06% of shares | low |
| May 19, 2026 | Williams Brinkley Ruth Director | Grant | Common Stock | $0 | +4K +15.53% | 29,750 0.03% of shares | low |
| May 4, 2026 | Reed Elizabeth E Executive | Exercise | Common Stock | $0 | +4K +4.04% | 109,461 0.12% of shares | low |
| Apr 13, 2026 | Reed Elizabeth E Executive | Grant | Common Stock | $0 | +14K +13.31% | 119,211 0.13% of shares | low |
| May 19, 2026 | Lyons Gary a Director | Grant | Common Stock | $0 | +4K +6.96% | 61,500 0.07% of shares | low |
| Jan 31, 2026 | Heerma Peter Executive | Grant | Common Stock | $0 | +26K +23.11% | 139,133 0.15% of shares | low |
| Jan 31, 2026 | Dube Eric M CEO | Grant | Common Stock | $0 | +114K +27.15% | 532,973 0.57% of shares | low |
| Jan 31, 2026 | Rote William E. Executive | Grant | Common Stock | $0 | +20K +19.80% | 121,533 0.13% of shares | low |
| Jan 31, 2026 | Cline Christopher R. Executive | Grant | Common Stock | $0 | +28K +30.55% | 120,213 0.13% of shares | low |
| Jan 31, 2026 | Inrig Jula Executive | Grant | Common Stock | $0 | +28K +32.59% | 114,441 0.12% of shares | low |
| Jan 31, 2026 | Calvin Sandra Executive | Grant | Common Stock | $0 | +15K +39.70% | 53,413 0.06% of shares | low |
| Jan 31, 2026 | Reed Elizabeth E Executive | Grant | Common Stock | $0 | +25K +27.82% | 115,380 0.12% of shares | low |
| Feb 4, 2026 | Cline Christopher R. Executive | Sell | Common Stock | $3.6K | -110 -0.10% | 111,226 0.12% of shares | low |
| Feb 4, 2026 | Inrig Jula Executive | Sell | Common Stock | $7.6K | -232 -0.22% | 105,706 0.11% of shares | low |
| Feb 4, 2026 | Reed Elizabeth E Executive | Sell | Common Stock | $16.7K | -509 -0.48% | 105,211 0.11% of shares | low |
| Jan 6, 2026 | Inrig Jula Executive | Sell | Common Stock | $16.8K | -445 -0.51% | 86,311 0.09% of shares | low |
| Feb 4, 2026 | Inrig Jula Executive | Sell | Common Stock | $49.7K | -2K -1.44% | 105,938 0.11% of shares | low |
| Feb 4, 2026 | Cline Christopher R. Executive | Sell | Common Stock | $52.5K | -2K -1.45% | 111,336 0.12% of shares | low |
| Apr 15, 2026 | Reed Elizabeth E Executive | Sell | Common Stock | $66.3K | -2K -1.46% | 105,211 0.11% of shares | low |
| Feb 4, 2026 | Reed Elizabeth E Executive | Sell | Common Stock | $79.7K | -2K -2.30% | 105,720 0.11% of shares | low |
| Jan 5, 2026 | Inrig Jula Executive | Sell | Common Stock | $81.6K | -2K -2.29% | 86,756 0.09% of shares | low |
| May 6, 2026 | Reed Elizabeth E Executive | Sell | Common Stock | $91.2K | -2K -1.93% | 105,211 0.11% of shares | low |
| May 5, 2026 | Reed Elizabeth E Executive | Sell | Common Stock | $101.4K | -2K -1.99% | 107,287 0.11% of shares | medium |
| Apr 14, 2026 | Reed Elizabeth E Executive | Exercise | Common Stock | $116.0K | +8K +5.03% | 156,711 0.17% of shares | low |
| Feb 17, 2026 | Reed Elizabeth E Executive | Sell | Common Stock | $122.1K | -4K -3.94% | 105,211 0.11% of shares | medium |
| Jan 23, 2026 | Dube Eric M CEO | Exercise | Common Stock | $125.8K | +8K +1.94% | 427,308 0.45% of shares | low |
| Apr 14, 2026 | Lyons Gary a Director | Exercise | Common Stock | $130.6K | +8K +13.91% | 65,500 0.07% of shares | low |
| Feb 3, 2026 | Calvin Sandra Executive | Sell | Common Stock | $139.2K | -4K -8.11% | 49,080 0.05% of shares | medium |
| May 15, 2026 | Coughlin Timothy Director | Sell | Common Stock | $141.3K | -3K -5.86% | 52,250 0.06% of shares | medium |
| Apr 1, 2026 | Reed Elizabeth E Executive | Exercise | Common Stock | $154.6K | +10K +9.50% | 115,211 0.12% of shares | low |
| Feb 17, 2026 | Reed Elizabeth E Executive | Sell | Common Stock | $156.2K | -6K -4.93% | 109,532 0.12% of shares | medium |
| Apr 14, 2026 | Reed Elizabeth E Executive | Exercise | Common Stock | $190.8K | +10K +8.39% | 129,211 0.14% of shares | low |
| Mar 16, 2026 | Reed Elizabeth E Executive | Exercise | Common Stock | $190.8K | +10K +9.50% | 115,211 0.12% of shares | low |
| Feb 17, 2026 | Reed Elizabeth E Executive | Exercise | Common Stock | $190.8K | +10K +9.50% | 115,211 0.12% of shares | low |
| Jan 20, 2026 | Reed Elizabeth E Executive | Exercise | Common Stock | $190.8K | +10K +11.08% | 100,270 0.11% of shares | low |
| Apr 15, 2026 | Reed Elizabeth E Executive | Sell | Common Stock | $217.5K | -5K -4.67% | 106,770 0.11% of shares | medium |
| Feb 3, 2026 | Inrig Jula Executive | Sell | Common Stock | $223.4K | -7K -6.08% | 107,485 0.11% of shares | medium |
| Feb 3, 2026 | Reed Elizabeth E Executive | Sell | Common Stock | $230.5K | -7K -6.22% | 108,205 0.11% of shares | medium |
| Feb 3, 2026 | Cline Christopher R. Executive | Sell | Common Stock | $232.6K | -7K -6.02% | 112,971 0.12% of shares | medium |
| Feb 3, 2026 | Heerma Peter Executive | Sell | Common Stock | $234.8K | -7K -5.25% | 131,823 0.14% of shares | medium |
| Jan 23, 2026 | Dube Eric M CEO | Sell | Common Stock | $244.2K | -8K -1.90% | 419,173 0.44% of shares | medium |
| Jun 12, 2026 | Coughlin Timothy Director | Exercise | Common Stock | $265.2K | +10K +17.78% | 66,250 0.07% of shares | low |
| Jan 20, 2026 | Reed Elizabeth E Executive | Sell | Common Stock | $273.4K | -10K -9.97% | 90,270 0.10% of shares | medium |
| Mar 16, 2026 | Reed Elizabeth E Executive | Sell | Common Stock | $280.9K | -10K -8.68% | 105,211 0.11% of shares | medium |
| Apr 1, 2026 | Reed Elizabeth E Executive | Sell | Common Stock | $300.0K | -10K -8.68% | 105,211 0.11% of shares | medium |
| Apr 14, 2026 | Reed Elizabeth E Executive | Sell | Common Stock | $302.5K | -7K -6.05% | 111,996 0.12% of shares | medium |
| Apr 14, 2026 | Lyons Gary a Director | Sell | Common Stock | $328.6K | -8K -12.21% | 57,500 0.06% of shares | medium |
| May 4, 2026 | Reed Elizabeth E Executive | Exercise | Common Stock | $359.2K | +20K +19.01% | 125,211 0.13% of shares | low |
| Apr 14, 2026 | Reed Elizabeth E Executive | Exercise | Common Stock | $359.2K | +20K +15.48% | 149,211 0.16% of shares | low |
| Feb 3, 2026 | Rote William E. Executive | Sell | Common Stock | $409.1K | -12K -10.24% | 109,087 0.12% of shares | medium |